Found 36 matching trials
Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection PHASE2 This phase II trial studies how well donor cytomegalovirus-specific cytotox...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma PHASE1 The goal of this clinical trial is to test a combined therapy approach (all...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus PHASE1 The main purpose of this project is to evaluate the efficiency of the injec...
Show More Location
Biotherapy department, Hôpital Necker - Enfants Malades
Learn More & Join Trial
Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation PHASE2 The investigators want to learn if CMV- and ADV-specific T-cells (cells tha...
Show More Location
St . Jude Children's Research Hospital
Learn More & Join Trial
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells PHASE1 The present trial will consist of the treatment of 20 pediatric and adult H...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial
Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants PHASE1 The purpose of this study is to test the safety of a transfusion of special...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant NA RATIONALE: Tests that measure certain changes in blood in patients at high ...
Show More Location
Multiple Locations
Learn More & Join Trial
CMV-CTL for the Treatment of CMV Infection After HSCT PHASE4 Human cytomegalovirus (CMV) infection is a major cause of morbidity and mor...
Show More Location
Shanghai Jiao Tong University Affilated Shanghai General Hospital
Learn More & Join Trial
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant PHASE1 This phase I/II trial studies the safety and toxicity of post-transplant tr...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
CMV-CMI in csCMVi After HSCT N/A Cytomegalovirus (CMV) reactivation is a common and serious complication aft...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial